Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
From Boxcars to a BillionDollar Network The Transformation Journey of a Transportation Powerhouse TrumpXi Summit Produces Deals on Soybeans and Rare Earths Amid Differing Perspectives on Tariff Cuts TD Cowen Revises Vertiv Price Target Upward Citing Growth Prospects AEM Holdings CEO Says AI Becoming as Vital as Water and Power Amid 450 Share Surge Microsofts New Trusted Tech Lead Faces Tension Between Speed and Responsibility in AI Development DLB Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher NTLA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Optimism in Gene Editing Pipeline Unisys Q1 2026 Earnings EPS Surges Past Expectations Despite Net Loss JAKK Q1 2026 Earnings EPS Surprises Positive but Revenue Details Absent Stock Dips CAKE Q1 2026 Earnings EPS Beats Estimates by 147 Modest Stock Uptick Nuveen Real Estate Income Fund JRS Edges Higher on Modest Gains Lands End LE Bounces 34 Gain as Stock Tests Resistance Near 1309 Kingsway Financial Services KFS Sees Mild Pullback Holds Near Support Zone MettlerToledo MTD Holds Steady Near 1100 as Support Levels Are Tested Consumer Sentiment Hits Fresh Record Low in May as Iran Conflict Fuels Inflation Worries Dropboxs Fully Remote Model Strengthens Hiring and Retention as Rivals Return to Office Amazon Reports RecordBreaking Thanksgiving Holiday Week Sales MillionDollar AI Talent War Escalates as Tech Giants Chase AGI Evotec Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Movement Starwood Property Trust STWD Q1 2026 Earnings EPS Miss Amid Stable Market Performance Twilio Q1 2026 Earnings EPS Surprise Beats Estimates as Profitability Improves Voyager Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response OGEN Q2 2023 Earnings NarrowerthanExpected Loss Boosts Investor Sentiment Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development